Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors
August 27, 2018 at 11:37 AM EDT
Results for a potential billion-dollar drug were encouraging, but left plenty of openings for competitors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.